Healthcare Technology Stocks Sector Close –Up; (OTCBB: HEME), (OTCBB: CYCA), (NASDAQ:HSTM), (NASDAQ:MDRX)

Point Roberts, WA (Investorideas.com Newswire) September 3, 2010- InvestorIdeas.com, leader in sector research for investors, reports on recent Healthcare Technology Stocks news and trading for September 3rd. Healthcare Technology Stocks include Healthmed Services Ltd. HEME, Cytta Corp. CYCA, Healthstream Inc. HSTM, A.D.A.M. Inc. ADAM and Allscripts Healthcare Solutions, Inc. MDRX Sector Snapshot: Trading at time or release Allscripts MDRX trading at $17.59 USD, up 0.25 (1.44%) A.D.A.M. Inc. ADAM trading at $ 5.50, up 0.03 (0.55%) Cytta Corp. CYCA trading at 0.0017 - 0.0018 Healthstream Inc. HSTM trading at $ 4.89 USD, up 0.03 (0.62%) Healthmed Services Ltd. HEME trading at $0.17 Healthcare Technology Stocks News: HealthMed Services HEME to Acquire Neural Communicator HealthMed Services Ltd., an innovative software development company, is pleased to announce that it has entered final negotiations to acquire all rights, title and interest to Neural Communicator software and hardware. Neural Communicator has developed brain/computer interface devices and software designed to enable people with extreme disabilities to communicate. The device detects eye movement, jaw contractions and ALPHA and BETA brain waves allowing hands free input. Neural Communicator is intended for people disabled in such a way that they cannot communicate by speech or by using their body. Biofeedback is used for computer input and controlling the application features. Full News: http://www.investorideas.com/news/9022.asp Allscripts Healthcare Solutions, Inc. MDRX; Allscripts and Eclipsys Merge Combination Creates the Largest Network in Healthcare Connecting 180,000 Physicians, 1,500 Hospitals and 10,000 Post-Acute Organizations Establishes Market Leader Focused on Enabling a Connected Community of Health Allscripts today will announce in a ceremony at the NASDAQ MarketSite in Times Square the completion of the merger of Allscripts-Misys Healthcare Solutions, Inc. with Eclipsys Corporation. Full news: visit www.allscripts.com. About Allscripts Allscripts MDRX provides innovative solutions that empower all stakeholders across the healthcare continuum to deliver world-class outcomes. The company's clinical, financial, connectivity and information solutions for hospitals, physicians and post-acute organizations are the essential technologies that enable a connected healthcare community. To learn more about Allscripts, please visit www.allscripts.com, Twitter, Facebook and YouTube. Market Snapshot: (at time of release) Dow 10,386.10 +66.00 +0.64% NASDAQ 2,218.91 +18.90 +0.86% S&P 500 1,098.13 +8.03 +0.74% 10 Yr Bond (%) 2.7170% +0.8900 Oil 73.36 -1.66 -2.21% Gold 1,240.80 -10.70 -0.85% About InvestorIdeas.com: InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires. Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/Research/Biotech,PharmaStocks.asp About our Biotech investor portal: BiotechIndustryStocks.com Portal is a global meeting place for investors and industry following the sector, within Investorideas.com. Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories. Disclaimer: The following news is paid for by third party on behalf of HealthMed Services Ltd (one thousand) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp C Van Zant: 800-665-0411 – cvanzant@investorideas.com Source – Investorideas.com